Literature DB >> 32864894

Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice.

Fangfang Wu1, Hongbin Sun2, Weigang Gong1,3, Xiaoli Li1, Zhaohui Pan1, Han Shan4, Zhijun Zhang1.   

Abstract

INTRODUCTION: The two-pore domain potassium channel TREK-1 is a member of background K+ channels that are thought to provide baseline regulation of membrane excitability. Recent studies have highlighted the putative role of TREK-1 in the action of antidepressants, and its antagonists might be potentially effective antidepressants. However, the mechanisms underlying the actions of TREK-1 are not yet fully understood.
METHODS: The expression of TREK-1 was examined in a mouse model of chronic unpredictable mild stress (CUMS) using immunoblotting. Neuron-specific genetic manipulation of TREK-1 was performed through adeno-associated virus. Behavioral tests were performed to evaluate depression-related behaviors. Electrophysiological recordings were used to evaluate synaptic plasticity. Golgi staining was used to examine neuroplasticity.
RESULTS: TREK-1 expression was increased in the mouse hippocampus after CUMS. Knockdown of TREK-1 in hippocampal neurons significantly attenuated depressive-like behaviors and prevented the decrease of CUMS-induced synaptic proteins in mice. Further examination indicated that neuron-specific knockdown of TREK-1 in the hippocampus prevented stress-induced impairment of glutamatergic synaptic transmission in the CA1 region. Moreover, chronic TREK-1 inhibition protected against CUMS-induced depressive-like behaviors and impairment of synaptogenesis in the hippocampus.
CONCLUSION: Our results indicate a role for TREK-1 in the modulation of synaptic plasticity in a mouse model of depression. These findings will provide insight into the pathological mechanism of depression and further evidence for a novel target for antidepressant treatment.
© 2020 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TREK-1; depression; hippocampus; mice; neuronal plasticity

Mesh:

Substances:

Year:  2020        PMID: 32864894      PMCID: PMC7816204          DOI: 10.1111/cns.13450

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  34 in total

1.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

Review 2.  The neuronal background K2P channels: focus on TREK1.

Authors:  Eric Honoré
Journal:  Nat Rev Neurosci       Date:  2007-04       Impact factor: 34.870

3.  Depression-Related Behavioral Tests.

Authors:  Timothy R Powell; Cathy Fernandes; Leonard C Schalkwyk
Journal:  Curr Protoc Mouse Biol       Date:  2012-06-01

Review 4.  The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior.

Authors:  Kathryn G Commons; Aram B Cholanians; Jessica A Babb; Daniel G Ehlinger
Journal:  ACS Chem Neurosci       Date:  2017-03-22       Impact factor: 4.418

Review 5.  The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission.

Authors:  Maurizio Popoli; Zhen Yan; Bruce S McEwen; Gerard Sanacora
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

Review 6.  Synaptic dysfunction in depression: potential therapeutic targets.

Authors:  Ronald S Duman; George K Aghajanian
Journal:  Science       Date:  2012-10-05       Impact factor: 47.728

7.  The Knockdown of TREK-1 in Hippocampal Neurons Attenuate Lipopolysaccharide-Induced Depressive-Like Behavior in Mice.

Authors:  Ajung Kim; Hyun-Gug Jung; Yeong-Eun Kim; Seung-Chan Kim; Jae-Yong Park; Seok-Geun Lee; Eun Mi Hwang
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

8.  Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions.

Authors:  Danielle M Gerhard; Ronald S Duman
Journal:  Curr Behav Neurosci Rep       Date:  2018-02-05

9.  An allosteric ligand-binding site in the extracellular cap of K2P channels.

Authors:  Qichao Luo; Liping Chen; Xi Cheng; Yuqin Ma; Xiaona Li; Bing Zhang; Li Li; Shilei Zhang; Fei Guo; Yang Li; Huaiyu Yang
Journal:  Nat Commun       Date:  2017-08-29       Impact factor: 14.919

10.  Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression.

Authors:  Ren-Hong Du; Fang-Fang Wu; Ming Lu; Xiao-Dong Shu; Jian-Hua Ding; Guangyu Wu; Gang Hu
Journal:  Redox Biol       Date:  2016-08-18       Impact factor: 11.799

View more
  4 in total

1.  Noninvasive Delivery of Biologicals to the Brain.

Authors:  Sheldon Jordan; Margaret Zielinski; Marcin Kortylewski; Taylor Kuhn; Alexander Bystritsky
Journal:  Focus (Am Psychiatr Publ)       Date:  2022-01-25

Review 2.  Two-Pore Domain Potassium Channel in Neurological Disorders.

Authors:  Punita Aggarwal; Sanjiv Singh; V Ravichandiran
Journal:  J Membr Biol       Date:  2021-06-24       Impact factor: 1.843

3.  GW117: A novel serotonin (5-HT2C ) receptor antagonist and melatonin (MT1 /MT2 ) receptor agonist with potential antidepressant-like activity in rodents.

Authors:  Nana Gao; Wei Zheng; Tiliwaerde Murezati; Wei Gu; Xiaorong Li; Zengliang Jin
Journal:  CNS Neurosci Ther       Date:  2021-03-01       Impact factor: 7.035

4.  Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice.

Authors:  Fangfang Wu; Hongbin Sun; Weigang Gong; Xiaoli Li; Zhaohui Pan; Han Shan; Zhijun Zhang
Journal:  CNS Neurosci Ther       Date:  2020-08-30       Impact factor: 5.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.